Bupivacaine HCl - CAS 18010-40-7
Catalog number: 18010-40-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H28N2O.HCl
Molecular Weight:
324.89
COA:
Inquire
Targets:
Others
Description:
Bupivacaine HCl binds to the intracellular portion of voltage-gated sodium channels and blocks sodium influx into nerve cells, used for treating cardiac arrhythmias.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1. Solid-state NMR studies of pharmaceutical solids in polymer matrices
Joseph W. Lubach • Brian E. Padden • Stephanie L. Winslow • Jonathon S. Salsbury. Anal Bioanal Chem (2004) 378 : 1504–1510
The multiple polymorphic and pseudopolymorphic forms of bupivacaine-HCl that can be generated upon heating or recrystallization are shown in Fig. 3. If bupivacaine HCl is heated at 100 °C for 12 h, the material becomes disordered, as indicated by the increase in the breadth of the lines in the NMR spectrum. However, the material does not become amorphous. Further heating to 170 °C for 12 h produces yet a different spectrum. This spectrum could be composed of either a mixture of two different forms, or there could be two different crystallographically non-equivalent sites in the unit cell. Yet another form can be generated by recrystallization from ethanol. There is a strong possibility that this is an ethanol solvate, as there is a peak at ~60 ppm that is characteristic of ethanol.
2. Different anesthetic agents-soaked sinus packings on pain management after functional endoscopic sinus surgery: which is the most effective?
Suheyl Haytoglu • Gokhan Kuran • Nuray Bayar Muluk • Osman Kursat Arıkan. Eur Arch Otorhinolaryngol (2016) 273:1769–1777
In the present study, we investigated the efficacy of local anesthetics soaked merocel sinus packs after FESS. Topical anesthetics are classified in two groups, amide and ester derivates. Lidocaine, Bupivacaine, Ropivacaine and Prilocaine are the amide group of topical anesthetic. In 5 groups, 2% lidocaine HCl, 0.25 % Bupivacaine HCl, 0.2 % Ropivacaine, 2 % Prilocaine and 0.9 % NaCl (Saline) were applied, respectively. In our study, preoperative Lund–Mackay CT Score values of the groups were not different. There was no significant difference between bleeding grade of the groups. In Bupivacaine group, number of gauze/24 h use was lower than lidocaine, ropivacaine and prilocaine groups. In saline group, number of gauze/24 h use was higher than lidocaine, ropivacaine and prilocaine groups.
3. The effect of bupivacaine•HCl on the physical properties of neuronal membranes
K. I. Koo & J. H. Bae & C. H. Lee & C. D. Yoon & J. H. Pyun & S. H. Shin & Y. C. Jeon & M. K. Bae. Protoplasma (2008) 234:3–12
Figure 5 shows that the anisotropy (r) of DPH in the TNBS untreated membrane (inner plus outer monolayers) decreased gradually (fluidization) with increasing bupivacaine HCl concentrations (Fig. 5, filled squares). There was a similar, but more gradual, decrease in the calculated anisotropy of the inner monolayer at any bupivacaine•HCl concentration (Fig. 5, filled triangles). The anisotropy of DPH in SPMVs inner monolayer incubated with 1 mM bupivacaine HCl was 0.182±0.005** (n=5, P<0.01), and the change in anisotropy value before and after adding 1 mM bupivacaine•HCl was 0.038. The values in the inner monolayer were 0.220±0.003 (n=5) and 0.269±0.005 (n=5) at 37°C and 25°C, respectively. Thus the effect of 1 mM bupivacaine HCl was equivalent to that produced by a temperature increase of approximate 9.3°C. However, there was no statistically significant decrease in the anisotropy (the rotational mobility range) of the outer monolayer at 0.01∼0.02 mM of the bupivacaine•HCl concentrations used. These results suggest that the fluidizing effect (range of rotational mobility) of bupivacaine•HCl is selective.
4. Controlled release of bupivacaine HCl through microchannels of biodegradable drug delivery device
Kang Ju Lee & Sung Yeun Yang & WonHyoung Ryu. Biomed Microdevices (2012) 14:583–593
Release of bupivacaine HCl in deionized water and phosphate buffered saline solution To assess the effect of release media, microfluidic devices containing BHCl were tested in both deionized water (DI water) and phosphate buffered saline (PBS) solutions. Two groups of devices were fabricated to have the channel lengths of 0.7 mm and one group of devices had the release channels of 1.6 mm. The amount of bupivacaine loaded in each device (2.4 mg/device on average)was determined such that the solubility limit of the analgesic was maintained over three days. Under this condition, diffusional transport of BHCl was expected to be at a constant rate for at least three days. As shown in Fig. 4, when devices with 0.7 mm long channels were placed in DI water, BHCl was released at a constant rate close to the estimated value from Table 1. However, devices with the same channel lengths (0.7 mm) was tested in a PBS solution, the release profile showed biphasic patterns. Until day one, it showed zero-order release almost identical to the devices in DI water.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 477-90-7 Bergenin

Bergenin
(CAS: 477-90-7)

Bergenin is trihydroxybenzoic acid glycoside and the C-glycoside of 4-O-methyl gallic acid.It shows a potent immunomodulatory effect.

CAS 19767-45-4 Mesna

Mesna
(CAS: 19767-45-4)

Mesna is converted to a free thiol compound in the kidney, where it binds to and inactivates acrolein and other urotoxic metabolites of ifosfamide and cyclophos...

Lotilaner
(CAS: 1369852-71-0)

Lotilaner is an insecticide and veterinary drug.

CAS 464-74-4 Arenobufagin

Arenobufagin
(CAS: 464-74-4)

Arenobufagin is a bufanolide steroid isolated from the Argentine toad Bufo arenarum. This compound exhibits anticancer chemotherapeutic and anti-angiogenic prop...

CAS 269730-03-2 RPI-1

RPI-1
(CAS: 269730-03-2)

RPI-1 is a cell-permeable, ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused growth arrest or regression in 81% treated tumors. It can also b...

CAS 35899-54-8 5'-Isobutylthio-5'-deoxyadenosine

5'-Isobutylthio-5'-deoxyadenosine
(CAS: 35899-54-8)

5'-Isobutylthio-5'-deoxyadenosine acts as a selectively spermine with IC50=8 uM.

CAS 313553-47-8 INH1

INH1
(CAS: 313553-47-8)

INH1 is a cell-permeable Hec1 inhibitor, which specifically disrupts the Hec1/Nek2 interaction.

ML192
(CAS: 460331-61-7)

ML192 is a selective ligands for GPR55 with 1080 nM potency for GPR55 and >45-fold antagonist and agonist selectivity against GPR35, CB1 and CB2.

Integrin Antagonist 1 hydrochloride
(CAS: 1629249-40-6)

Integrin Antagonist 1 hydrochloride, a naphthyridine derivative, is a small molecule antagonist of integrin αvβ6. In the Fluorescence Polarisation Assay: human ...

CAS 138736-73-9 HAMNO

HAMNO
(CAS: 138736-73-9)

HAMNO is a novel protein interaction inhibitor of replication protein A (RPA), which is involved in the ATR/Chk1 pathway. HAMNO acts by binding to the N-termina...

BMS 182264
(CAS: 127749-54-6)

BMS 182264 is a bio-active chemical, but few detailed information has been published yet.

CAS 19992-50-8 ML329

ML329
(CAS: 19992-50-8)

ML329 is a small molecule MITF inhibitor that inhibits the expression of numerous micropthalmia-associated transcription factor (MITF) target genes and blocks t...

CAS 104098-48-8 Imazameth

Imazameth
(CAS: 104098-48-8)

Imazapic, a 2-substituted imidazole derivative, is a selective herbicide which could be commonly used for the preand post-emergent control of some sorts of annu...

Crustacean Cardioactive Peptide CCAP

Crustacean Cardioactive Peptide (CCAP), originally identified in the pericardial organs of the shore crab, Carcinus means, is a highly conserved, amidated cycli...

CAS 172430-46-5 O-Desaryl ranolazine

O-Desaryl ranolazine
(CAS: 172430-46-5)

O-Desaryl Ranolazine, a piperazine derivative, has been found to be a ranolazine metabolite which is a partial fatty acid oxidation inhibitor and could be used ...

EBI-907
(CAS: 1581764-31-9)

EBI-907, an isoquinolin derivative, has been found to be a B-RafV600E inhibitor and exhibit activities against some oncogenic kinases at some extent. The resear...

Epetirimod
(CAS: 227318-71-0)

Epetirimod is a small-molecule immune-response modifier intended for the topical treatment of cervical human papilloma virus (HPV) infection and cervical dyspla...

CAS 1391054-02-6 Vigabatrin Hydrochloride

Vigabatrin Hydrochloride
(CAS: 1391054-02-6)

A novel antiepileptic drug. Antidepressant; antipsychotic; anxiolytic.

CAS 58-93-5 Hydrochlorothiazide

Hydrochlorothiazide
(CAS: 58-93-5)

Hydrochlorothiazide is a diuretic medication often used to treat high blood pressure and swelling due to fluid build up.

CAS 6233-83-6 Oxytocin acetate

Oxytocin acetate
(CAS: 6233-83-6)

Oxytocin acetate is a mammalian neurohypophysial hormone. Its actions are mediated by specific, high-affinity oxytocin receptors. Oxytocin is normally produced ...

Chemical Structure

CAS 18010-40-7 Bupivacaine HCl

Quick Inquiry

Verification code

Featured Items